Variant report
Variant | nsv538281 |
---|---|
Chromosome Location | chr6:65614166-65656384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:65644339..65646278-chr6:65650850..65653473,2 | K562 | blood: | |
2 | chr6:65644339..65646278-chr6:65650850..65653473,2 | K562 | blood: | |
3 | chr6:65639435..65641072-chr6:65642848..65644357,2 | MCF-7 | breast: | |
4 | chr6:65639435..65641072-chr6:65642848..65644357,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144481540 | chr6:65614173-65614174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550760364 | chr6:65614175-65614176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570681979 | chr6:65614210-65614211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539670846 | chr6:65614216-65614217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181278713 | chr6:65614285-65614286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571196327 | chr6:65614341-65614342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532303777 | chr6:65614346-65614347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573179045 | chr6:65614356-65614357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370234958 | chr6:65614390-65614391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535525337 | chr6:65614405-65614406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555415796 | chr6:65614416-65614417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148430629 | chr6:65614470-65614471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374011423 | chr6:65614475-65614476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77513451 | chr6:65614558-65614559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185871220 | chr6:65614567-65614568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145016100 | chr6:65614571-65614572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147574280 | chr6:65614608-65614609 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1475211 | chr6:65614618-65614619 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs528069236 | chr6:65614627-65614628 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141832162 | chr6:65614723-65614724 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs62416460 | chr6:65614732-65614733 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530593084 | chr6:65614746-65614747 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550699328 | chr6:65614749-65614750 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs16895996 | chr6:65614779-65614780 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs145695960 | chr6:65614784-65614785 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566855493 | chr6:65614791-65614792 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534196222 | chr6:65614796-65614797 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574929350 | chr6:65614801-65614802 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546868878 | chr6:65614804-65614805 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566679639 | chr6:65614809-65614810 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535439441 | chr6:65614818-65614819 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555305268 | chr6:65614883-65614884 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372735482 | chr6:65614905-65614906 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35593824 | chr6:65614941-65614942 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189016676 | chr6:65614953-65614954 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575239399 | chr6:65615027-65615028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537911684 | chr6:65615037-65615038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557873747 | chr6:65615097-65615098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs578122849 | chr6:65615136-65615137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531104317 | chr6:65615190-65615191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112472091 | chr6:65615193-65615194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577596992 | chr6:65615214-65615215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554431719 | chr6:65615222-65615223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs36054628 | chr6:65615241-65615242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574216797 | chr6:65615269-65615270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543363308 | chr6:65615304-65615305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370263079 | chr6:65615334-65615335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73767162 | chr6:65615347-65615348 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs376362145 | chr6:65615353-65615354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530528675 | chr6:65615393-65615394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65614000-65614600 | Enhancers | HUVEC | blood vessel |
2 | chr6:65614200-65615400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr6:65614600-65615000 | Flanking Active TSS | HUVEC | blood vessel |
4 | chr6:65615000-65615600 | Enhancers | HUVEC | blood vessel |
5 | chr6:65621200-65622000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:65623600-65624400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr6:65623800-65624200 | Enhancers | Hela-S3 | cervix |
8 | chr6:65626000-65626800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:65626200-65626600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr6:65631800-65632200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr6:65635600-65636200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr6:65640600-65641000 | Enhancers | Fetal Brain Female | brain |
13 | chr6:65640800-65642200 | Weak transcription | Esophagus | oesophagus |
14 | chr6:65642200-65642600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |